+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Insulin Delivery Devices Market - Global Forecast 2026-2032- Product Image
Insulin Delivery Devices Market - Global Forecast 2026-2032- Product Image
New

Insulin Delivery Devices Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 180 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5675007
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The insulin delivery devices market is rapidly transforming global diabetes management, driven by continual technological advancement and a strategic focus on patient-centric solutions. Senior leaders across healthcare, manufacturing, and supply chains must adapt to a landscape where digital integration, innovation, and responsive operations define competitive outcomes.

Market Snapshot: Insulin Delivery Devices Market Growth and Outlook

The Insulin Delivery Devices Market grew from USD 33.86 billion in 2025 to USD 36.45 billion in 2026, and is projected to reach USD 58.63 billion by 2032 at a CAGR of 8.15%. Market expansion is underpinned by a rising global diabetes population, increased focus on personalized medicine, and the rapid adoption of digital health solutions across healthcare infrastructures worldwide. Demand for advanced, user-friendly delivery options and integrated digital platforms is accelerating adoption in both mature and emerging healthcare economies.

Scope & Segmentation of the Insulin Delivery Devices Market

This report covers a comprehensive analysis of the insulin delivery ecosystem, focusing on pivotal segments and regional dynamics to provide actionable intelligence:

  • Delivery Methods: Covers pens, pumps, syringes, and jet injectors, highlighting the trend toward simplicity and refinement in device design.
  • Insulin Formulations: Includes rapid-acting, long-acting, pre-mixed, and intermediate-acting types for varied therapy needs.
  • Distribution Channels: Details on hospital pharmacies, retail pharmacies, and online pharmacies, each influencing access and delivery responsiveness.
  • End Users: Examines adoption patterns across ambulatory care, clinics, homecare, and hospital environments, where demand for user training and device support is key.
  • Applications: Addresses tailored solutions for gestational, Type 1, and Type 2 diabetes, reflecting evolving therapeutic protocols.
  • Age Demographics: Segments pediatric, adult, and geriatric groups, emphasizing device adaptation to user capability and comfort.
  • Regions Covered: Analysis spans Americas, Europe Middle East & Africa, and Asia-Pacific to capture distinct growth rates, reimbursement models, and patient engagement trends.
  • Technology Innovations: Features smart pens, micro infusion pumps, needle-free injectors, digital platforms, and closed-loop systems that enhance therapeutic precision and patient experience.

Key Takeaways for Senior Decision-Makers

  • Technological breakthroughs, such as intuitive user interfaces and digital monitoring tools, have elevated adherence and clinical outcomes while streamlining provider workflows.
  • Patient-centric innovation is enabling wider acceptance and usage, notably through needle-free devices and compact, accessible designs for all age groups.
  • The interplay between automation, analytics, and remote monitoring is fundamentally reshaping delivery paradigms, promoting agile management and personalized care plans.
  • Regional diversity in healthcare policy and infrastructure demands product customization and strategic localization of manufacturing to meet varying regulatory, economic, and cultural expectations.
  • Strategic alliances across technology development, supply chain optimization, and local market entry are key to sustaining competitive differentiation and maintaining device accessibility.
  • Portfolio diversification and targeted education programs support broad adoption, catering to the needs of both advanced healthcare systems and resource-constrained environments.

Tariff Impact: U.S. Policies and Global Supply Chain Trends

Recent United States tariffs on medical devices are influencing cost structures, leading manufacturers toward regionally focused sourcing, automation-driven production, and alliance-driven procurement strategies. These shifts encourage alternate manufacturing sites, supply chain resilience measures, and continuous dialogue with regulatory authorities to navigate compliance and optimize operational agility. Portfolio adjustment further insulates manufacturers from policy-driven cost fluctuations, ensuring diverse technologies remain accessible across markets.

Methodology & Data Sources

A multi-pronged research approach includes primary interviews with clinical, operational, and executive stakeholders, and thorough secondary reviews of journals, market filings, and public disclosures. Quantitative and qualitative evidence is triangulated using comparative and trend analysis, enriched by scenario planning and expert validation for robust market forecasts and actionable insights.

Why This Report Matters

  • Delivers executive-level intelligence on evolving technologies, regional growth drivers, and regulatory landscapes specific to insulin delivery devices.
  • Equips senior stakeholders to anticipate supply chain shifts, refine portfolio strategies, and align operations to emerging patient and policy requirements.
  • Enables data-backed, actionable planning for sustainable growth, investment prioritization, and improved patient care outcomes.

Conclusion

The insulin delivery devices market is defined by rapid evolution, advancing integration, and an intensifying focus on patient preferences and ecosystem alignment. Leaders able to leverage these insights are well positioned to thrive amid dynamic industry transformation.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Insulin Delivery Devices Market, by Delivery Method
8.1. Insulin Pens
8.2. Insulin Pumps
8.3. Insulin Syringes
8.4. Jet Injectors
9. Insulin Delivery Devices Market, by Insulin Type
9.1. Intermediate-Acting
9.2. Long-Acting
9.3. Pre-Mixed
9.4. Rapid-Acting
10. Insulin Delivery Devices Market, by Distribution Channel
10.1. Hospital Pharmacies
10.2. Online Pharmacies
10.3. Retail Pharmacies
11. Insulin Delivery Devices Market, by End User
11.1. Ambulatory Care Centers
11.2. Clinics
11.3. Homecare Settings
11.4. Hospitals
12. Insulin Delivery Devices Market, by Application
12.1. Gestational Diabetes
12.2. Type 1 Diabetes
12.3. Type 2 Diabetes
13. Insulin Delivery Devices Market, by Age Group
13.1. Adult
13.2. Geriatric
13.3. Pediatric
14. Insulin Delivery Devices Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Insulin Delivery Devices Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Insulin Delivery Devices Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Insulin Delivery Devices Market
18. China Insulin Delivery Devices Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Abbott Laboratories
19.6. Ascensia Diabetes Care Holdings AG
19.7. B. Braun SE
19.8. Biocon
19.9. Debiotech SA
19.10. Eli Lilly and Company
19.11. Embecta Corp.
19.12. Gerresheimer AG
19.13. ICU Medical, Inc.
19.14. Insulet Corporation
19.15. Jiangsu Delfu medical device Co.,Ltd
19.16. Johnson & Johnson Services, Inc.
19.17. MannKind Corporation
19.18. Medtronic PLC
19.19. Nipro Corporation
19.20. Novo Nordisk A/S
19.21. Owen Mumford Ltd.
19.22. Roche Diabetes Care, Inc.
19.23. Sanofi S.A.
19.24. Sequel Med Tech, LLC
19.25. SOOIL Developments Co., Ltd
19.26. Tandem Diabetes Care, Inc.
19.27. Terumo Corporation
19.28. Wockhardt Limited
19.29. Ypsomed AG
List of Figures
FIGURE 1. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL INSULIN DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL INSULIN DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN PENS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN PENS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN PENS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN PUMPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN SYRINGES, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN SYRINGES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN SYRINGES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY JET INJECTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY JET INJECTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY JET INJECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INTERMEDIATE-ACTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INTERMEDIATE-ACTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INTERMEDIATE-ACTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY LONG-ACTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY LONG-ACTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY LONG-ACTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY PRE-MIXED, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY PRE-MIXED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY PRE-MIXED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY RAPID-ACTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY RAPID-ACTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY RAPID-ACTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY GESTATIONAL DIABETES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY GESTATIONAL DIABETES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY TYPE 1 DIABETES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY TYPE 1 DIABETES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY TYPE 2 DIABETES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY TYPE 2 DIABETES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. AMERICAS INSULIN DELIVERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 73. AMERICAS INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 74. AMERICAS INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 75. AMERICAS INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 76. AMERICAS INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 77. AMERICAS INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 78. AMERICAS INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 79. NORTH AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. NORTH AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 81. NORTH AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 82. NORTH AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 83. NORTH AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 84. NORTH AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 85. NORTH AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 86. LATIN AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. LATIN AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 88. LATIN AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 89. LATIN AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 90. LATIN AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 91. LATIN AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 92. LATIN AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 100. EUROPE INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. EUROPE INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 102. EUROPE INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 103. EUROPE INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 104. EUROPE INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 105. EUROPE INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 106. EUROPE INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 107. MIDDLE EAST INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. MIDDLE EAST INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 109. MIDDLE EAST INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 110. MIDDLE EAST INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 111. MIDDLE EAST INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 112. MIDDLE EAST INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 113. MIDDLE EAST INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 114. AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 116. AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 117. AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 118. AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 119. AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 120. AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 121. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 123. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 125. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 126. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 127. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 129. ASEAN INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. ASEAN INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 131. ASEAN INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 132. ASEAN INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 133. ASEAN INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 134. ASEAN INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 135. ASEAN INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 136. GCC INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 137. GCC INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 138. GCC INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 139. GCC INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 140. GCC INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 141. GCC INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 142. GCC INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 143. EUROPEAN UNION INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. EUROPEAN UNION INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 145. EUROPEAN UNION INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 146. EUROPEAN UNION INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 147. EUROPEAN UNION INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 148. EUROPEAN UNION INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 149. EUROPEAN UNION INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 150. BRICS INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. BRICS INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 152. BRICS INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 153. BRICS INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 154. BRICS INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 155. BRICS INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 156. BRICS INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 157. G7 INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 158. G7 INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 159. G7 INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 160. G7 INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 161. G7 INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 162. G7 INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 163. G7 INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 164. NATO INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. NATO INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 166. NATO INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 167. NATO INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 168. NATO INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 169. NATO INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 170. NATO INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 173. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 174. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 175. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 176. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 177. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 178. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 179. CHINA INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 180. CHINA INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 181. CHINA INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
TABLE 182. CHINA INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 183. CHINA INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 184. CHINA INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 185. CHINA INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Insulin Delivery Devices market report include:
  • Abbott Laboratories
  • Ascensia Diabetes Care Holdings AG
  • B. Braun SE
  • Biocon
  • Debiotech SA
  • Eli Lilly and Company
  • Embecta Corp.
  • Gerresheimer AG
  • ICU Medical, Inc.
  • Insulet Corporation
  • Jiangsu Delfu medical device Co.,Ltd
  • Johnson & Johnson Services, Inc.
  • MannKind Corporation
  • Medtronic PLC
  • Nipro Corporation
  • Novo Nordisk A/S
  • Owen Mumford Ltd.
  • Roche Diabetes Care, Inc.
  • Sanofi S.A.
  • Sequel Med Tech, LLC
  • SOOIL Developments Co., Ltd
  • Tandem Diabetes Care, Inc.
  • Terumo Corporation
  • Wockhardt Limited
  • Ypsomed AG

Table Information

Report AttributeDetails
No. of Pages180
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 36.45 Billion
Forecasted Market Value ( USD ) by 2032 $ 58.63 Billion
Compound Annual Growth Rate8.1%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Smart Insulin Pens & Pumps Market - Global Forecast 2026-2032 - Product Image

Smart Insulin Pens & Pumps Market - Global Forecast 2026-2032

  • Report
  • 181 Pages
  • Global
From
Non-invasive Insulin Market - Global Forecast 2026-2032 - Product Image

Non-invasive Insulin Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Insulin Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Insulin Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From
Human Insulin Market 2025-2033 - Product Image

Human Insulin Market 2025-2033

  • Report
  • 145 Pages
  • Global
From
Insulin Delivery Device Market by Type (Insulin Pens (Reusable, Disposable), Insulin Pumps (Tethered, Tubeless), Insulin Pen Needle (Standard, Safety), Insulin Syringes, Others), Disease Type (Type 1 Diabetes, Type 2 Diabetes) - Global Forecast to 2030 - Product Image

Insulin Delivery Device Market by Type (Insulin Pens (Reusable, Disposable), Insulin Pumps (Tethered, Tubeless), Insulin Pen Needle (Standard, Safety), Insulin Syringes, Others), Disease Type (Type 1 Diabetes, Type 2 Diabetes) - Global Forecast to 2030

  • Report
  • 379 Pages
  • Global
From

About the Market

The Insulin Delivery market is a subset of the larger Diabetes Devices market. It includes products and services that help people with diabetes manage their insulin levels. These products range from insulin pumps and pens to continuous glucose monitors and other accessories. Insulin pumps are the most popular type of insulin delivery device, as they allow for more precise and consistent dosing than traditional injections. Continuous glucose monitors provide real-time data on glucose levels, allowing for more accurate insulin dosing. Other accessories, such as infusion sets and reservoirs, are also available to help people with diabetes manage their insulin levels. Some of the major companies in the Insulin Delivery market include Medtronic, Insulet, Tandem Diabetes Care, and Animas. Other companies, such as Roche, Abbott, and Dexcom, also offer products and services in this market. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.